ARCHIVES

Cancer Registry Says Paper By Jon Sudbo Was Based On Fabricated Data.

This article is from The Cancer Letter archive.

Vol. 32 No. 03 | January 27, 2006

Download PDF Visit The Full Archive

Related Articles

The Selling Begins: CT Offered Beyond High-Risk Group

November 26, 2010

FDA Grants Six-Month Priority Review To Nolvadex For DCIS Adjuvant Treatment.

March 31, 2000

How a two-faced media covered cancer: Promoting research—and cigarettes

April 29, 2022

Interest Picks Up In SBIR, NCI May Not Gave To Face Choice of Giving Money Back Or Paying to 500 Level

November 23, 1984

NCI Plans Preclinical Studies Of Endoxifen, A Tamoxifen Metabolite.

August 7, 2009

NIH Recovery Act Announcements

March 27, 2009